Mersana Therapeutics, Inc.
MRSN
$7.65
-$0.10-1.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 76.97M | 102.29M | 134.62M | 155.17M | 162.74M |
| Total Receivables | 266.00K | -- | -- | 1.00M | 1.57M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.90M | 3.58M | 2.28M | 4.39M | 4.65M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 321.00K | -- | -- | -- |
| Total Current Assets | 80.14M | 106.19M | 136.90M | 160.56M | 168.96M |
|
|
|||||
| Total Current Assets | 80.14M | 106.19M | 136.90M | 160.56M | 168.96M |
| Net Property, Plant & Equipment | 3.93M | 5.63M | 6.78M | 8.00M | 9.19M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 500.00K | 657.00K | 978.00K | 978.00K | 978.00K |
| Total Assets | 84.57M | 112.47M | 144.66M | 169.53M | 179.13M |
|
|
|||||
| Total Accounts Payable | 2.92M | 4.37M | 4.33M | 2.03M | 3.01M |
| Total Accrued Expenses | 13.62M | 12.97M | 18.96M | 18.63M | 17.78M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.62M | 16.46M | 16.40M | 15.21M | 11.99M |
| Total Finance Division Other Current Liabilities | 22.18M | 24.35M | 22.76M | 32.43M | 29.40M |
| Total Other Current Liabilities | 22.18M | 24.35M | 22.76M | 32.43M | 29.40M |
| Total Current Liabilities | 59.34M | 58.16M | 62.46M | 68.30M | 62.18M |
|
|
|||||
| Total Current Liabilities | 59.34M | 58.16M | 62.46M | 68.30M | 62.18M |
| Long-Term Debt | -- | 7.90M | 10.95M | 14.00M | 17.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 262.00K | 1.30M | 2.32M | 3.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 78.38M | 77.02M | 79.46M | 83.87M | 87.57M |
| Total Liabilities | 137.72M | 143.34M | 154.17M | 168.48M | 170.70M |
|
|
|||||
| Common Stock & APIC | 890.83M | 888.81M | 886.03M | 882.46M | 878.43M |
| Retained Earnings | -943.97M | -919.68M | -895.55M | -881.44M | -869.94M |
| Treasury Stock & Other | -- | -- | 10.00K | 25.00K | -71.00K |
| Total Common Equity | -53.15M | -30.87M | -9.51M | 1.05M | 8.43M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -53.15M | -30.87M | -9.51M | 1.05M | 8.43M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -53.15M | -30.87M | -9.51M | 1.05M | 8.43M |
|
|
|||||